Baillie Gifford - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$31,839
+23.5%
231
+16.1%
0.00%
Q4 2022$25,786
+17.2%
1990.0%0.00%
Q3 2022$22,000
+46.7%
1990.0%0.00%
Q2 2022$15,000
+7.1%
199
+12.4%
0.00%
Q1 2022$14,000
-12.5%
1770.0%0.00%
Q4 2021$16,0000.0%1770.0%0.00%
Q3 2021$16,0000.0%177
-13.7%
0.00%
Q2 2021$16,000
+6.7%
2050.0%0.00%
Q1 2021$15,000
-50.0%
205
+15.2%
0.00%
Q4 2020$30,0001780.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders